Recombinant factor VIII (Saman daroo 8)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant factor VIII (Saman daroo 8)
Drug Alias NameSafacto
ClassificationBiologics
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSaman Daroo 8
China Registration ClassN/A

Develop Information

Active CompaniesSaman Daroo 8
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A